STOCK TITAN

CANN AMERICAN CORP - CNNA STOCK NEWS

Welcome to our dedicated page for CANN AMERICAN news (Ticker: CNNA), a resource for investors and traders seeking the latest updates and insights on CANN AMERICAN stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CANN AMERICAN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CANN AMERICAN's position in the market.

Rhea-AI Summary

Cann American Corp. (OTC PINK:CNNA) has announced the launch of Prodigy Health Plus, part of its Prodigy Elite Group. Prodigy Health Plus offers healthcare discount plans covering a range of services including dental, vision, prescriptions, and telehealth, aiming to make healthcare more affordable and accessible. The company emphasizes wellness, preventive care, and strong customer support backed by healthcare provider partnerships. Prodigy Elite Group plans to introduce up to seven more divisions soon. CNNA is finalizing its audit and Form 10 filing to regain full reporting compliance and expects to resume trading shortly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Cann American Corp. announces the closing of the Liberty Health Plus acquisition and name change to Prodigy Health Plus. The new company offers affordable access to various healthcare services and free pharmacy membership. The audit process is nearing completion, with significant updates expected in the coming weeks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.98%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.56%
Tags
none
-
Rhea-AI Summary

Cann American Corp. (OTC Pink:CNNA) has announced the opening of a new satellite office for its subsidiary, Prodigy Stem Cell, in Orlando, Florida, as part of its growth strategy. The 3,000 sq. ft. facility will cater to clients in the Orlando and Winter Park areas, which are rich in tourism and sports training facilities. The CEO, Jason Tucker, emphasized the plans for significant revenue growth by expanding Prodigy's brand. The company is targeting to establish partnerships in the region and will gradually launch Prodigy-branded wellness centers nationwide.

This strategic move follows Prodigy’s engagement with high-profile clients in the area, and the company plans to keep shareholders informed about its progress.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20%
Tags
none
-
Rhea-AI Summary

Cann American Corp. (OTC PINK:CNNA) announced a shareholder update highlighting the completion of its acquisition of Prodigy Stem Cell on March 1, 2023. This acquisition aims to enhance the Company's direction in alternative therapeutics, particularly in the rapidly growing stem cell market, projected to reach $30 billion by 2030. Prodigy plans to distribute its products to various health and wellness facilities and open new branded wellness centers, starting with a facility in Florida. The Company is also preparing for an up-listing to the SEC reporting tier, aiming for a broader market presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
Rhea-AI Summary

Cann American Corp. (OTC PINK:CNNA) provided a 2023 shareholder update, detailing the unwind of a prior asset purchase agreement with a gaming firm. Management aims to uplist to SEC reporting and restructure its debt to preserve capital. The company has entered a new MOU with a biopharmaceutical company valued at approximately $12 billion, aiming for strategic expansion beyond its cannabis-related assets. CEO Jason Black expressed optimism about this new direction, stating the acquisition target is more appealing from an industry and revenue perspective.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Cann American Corp. (OTC PINK: CNNA) announced a binding letter of intent to acquire a 75% majority stake in Valkyrie Systems Inc. by exchanging 10 million series C preferred shares. This acquisition aims to enhance Cann American's portfolio with Valkyrie's military-focused training services and technology, notably the upcoming Valkyrie One VR simulator, targeted at the US military. CEO Alexander Woods-Leo expressed optimism about the potential for substantial revenue growth through military contracts. The deal is expected to close within 10 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20%
Tags
none
-
Rhea-AI Summary

Cann American Corp. (OTC Pink: CNNA) announced the completion of an asset purchase of Mark2media Group on October 31, 2022, making it a majority-owned subsidiary. This technology company aims to develop applications globally using a unique business model to reduce user costs. Following the acquisition, Alexander Woods-Leo was appointed CEO and Director of Cann American. The new management plans to diversify the company further, pursue additional acquisitions, restructure debt to enhance shareholder value, and begin an audit process for potential up-listing to the OTCQB exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.78%
Tags
none
Rhea-AI Summary

Cann American Corp. (OTC PINK:CNNA) has announced a binding letter of intent to acquire an 80% stake in Mark2media Group by exchanging 1.5 million series B preferred shares. Mark2media, a tech company registered with major platforms, aims to reduce user costs through innovative applications. The acquisition is set to close on October 31, 2022, coinciding with a management transition, as Jason Black steps down as CEO, replaced by Alex Woods-Leo. The company also plans to focus on expanding its technology-driven cannabis delivery application, Cannagram.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-34.72%
Tags
none

FAQ

What is the current stock price of CANN AMERICAN (CNNA)?

The current stock price of CANN AMERICAN (CNNA) is $0.0029 as of December 24, 2024.

What is the market cap of CANN AMERICAN (CNNA)?

The market cap of CANN AMERICAN (CNNA) is approximately 994.3K.

CANN AMERICAN CORP

OTC:CNNA

CNNA Rankings

CNNA Stock Data

994.34k
265.00M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Orlando